Publications
admin June 4th, 2007
2010
Cox AR. MMR: a saga of bad science and scare stories that swayed healthcare professionals. The Pharmaceutical Journal 2010:284:157 [text]
Ferner RE, Hughes DA, Aronson JK. NICE and new: appraising innovation.BMJ 2010 Jan 5;340:b5493
Ferner RE, Aronson JK. EIDOS: a mechanistic classification of adverse drug effects. Drug Saf. 2010;33(1):15-23
Coleman JJ, Butt TF. Antihypertensive Drugs. In: Side Effects of Drugs Annual 32. Aronson JK (Ed). Elsevier; Amsterdam, 2010. (with editor)
McDowell SE, Mt-Isa S, Ashby D, Ferner RE. Where errors occur in the preparation and administration of intravenous medicines: a systematic review and Bayesian analysis. Qual Saf Health Care (accepted for publication).
Cox AR, Anton C, McDowell SE, Marriott JF, Ferner RE. Correlates of spontaneous reporting of adverse drug reactions within primary care: the paradox of low prescribers who are high reporters. Br J Clin Pharmacol (accepted for publication).
2009
Anton C, Cox AR, Ferner RE. Improving follow-up rates in spontaneous adverse drug reaction reporting: effectiveness of a targeted letter used by a regional centre in the UK. Drug Saf. 2009;32(12):1135-40
Ferner RE. The epidemiology of medication errors: the methodological difficulties. Br J Clin Pharmacol 2009 ;67(6):614-20
McDowell SE, Ferner HS, Ferner RE. The pathophysiology of medication errors: how and where they arise. Br J Clin Pharmacol 2009;67(6):605-13
Members of EMERGE, Erice Medication Errors Research Group, Agrawal A, Aronson JK, Britten N, Ferner RE, de Smet PA, Fialová D, Fitzgerald RJ, Liki? R, Maxwell SR, Meyboom RH, Minuz P, Onder G, Schachter M, Velo G. Medication errors: problems and recommendations from a consensus meeting. Br J Clin Pharmacol 2009 ;67(6):592-8
Ferner RE, McDowell SE. A model for NICE in the US BMJ 2009 ;338:b2221
Aronson JK, Barnett DB, Breckenridge AM, Ferner RE, Jackson P, Maxwell SR, McInnes GT, Rawlins MD, Ritter JM, Routledge P, Walley TJ, Webb DJ, Williams D, Woods KL.The UK’s NHS and pharma: need for more clinical pharmacologists. Lancet 2009;373(9671):1251-2
Aronson JK, Price D, Ferner RE. A strategy for regulatory action when new adverse effects of a licensed product emerge. Drug Saf. 2009;32(2):91-8
NJ Langford, K Tonks, M Singh. Out-patient detection of deep vein thrombosis using a combination of risk scoring and strain-gauge plethysmography: a follow-up study. Acute Medicine 2009;8:134-137
Ferner RE, McDowell SE. A model for NICE in the US. BMJ 2009;388;b2221
McDowell SE, Ferner HS, Ferner RE. The pathophysiology of medication errors: how and where they arise. Br J Clin Pharmacol 2009;67:605-613.
Cox AR, McDowell S. A Response to the article on the Association between Paracetamol/Acetaminophen: Use and Autism by Stephen T. Schultz. Autism 2009;13:123-124.
The educational effects of portfolios on undergraduate student learning: A Best Evidence Medical Education (BEME) systematic review. BEME Guide No. 11 Buckley SG, Coleman JJ, Davison I, Khan KS., Zamora J, Malick S, Morley D, Pollard D, Ashcroft T, Popovic C, Sayers J. Medical Teacher 2009; 31 (4): 282-298.
Coleman JJ, Butt TF. Antihypertensive Drugs. In: Side Effects of Drugs Annual 31. Aronson JK (Ed). Elsevier; Amsterdam, 2009.
Management of hypoglycaemia at night in a univeristy teaching hospital. McAloon CJ, Coleman JJ, Narendran P. Diabetic Medicine; 2009, 24 (Suppl. 1): 133-132. (Presented at Diabetes UK, 2009)
Development of an automated system to identify explanatory or contributory factors for acute hospital readmission. Ray D, Coleman JJ, Dabhi V, Cook J, Rosser D. (Presented at the Patient Safety Congress, Birmingham 2009)
The development of a hazard framework for ePrescribing. Slee A, Lewis K, Coleman JJ. (Presented at the Patient Safety Congress, Birmingham 2009)
Comprehensive analysis of a medication errors related to electronic prescribing – example of time-adjacent enoxaparin prescriptions. Coleman JJ, Nightingale P, Young I, Clark I. (Presented at the Patient Safety Congress, Birmingham 2009)
The Relationship Between Baseline Testing of Serum Electrolytes and Creatinine and Adverse Outcomes in Patients Treated with Antihypertensive Drugs: An Analysis Using Propensity Score Matching Methods
McDowell SE, Coleman JJ, Evans SJW, Ferner RE. Drug Safety 2009; 32(10): 912 (Presented at the 9th Annual Meeting of ISoP Reims, France 6-9 October 2009)
2008
Kay N, Green A, McDowell SE, Ferner RE. Should doctors who make clinical errors be charged with manslaughter? A survey of medical professionals and members of the public. Med Sci Law 2008 ;48(4):317-24
Ferner RE. Did the drug cause death? Codeine and breastfeeding. Lancet 2008 ;372(9639):606-8
Ferner RE. Post-mortem clinical pharmacology. Br J Clin Pharmacol 2008;66(4):430-43
Halpern J, Holder, R, Langford NJ. Ethnicity and other risk factors for acute lower limb cellulitis: a UK -based prospective case-control study. British Journal of Dermatology 2008 e-pub DOI 10.1111/j.1365-2133.2008.08489
Oluboyede Y, Goodacre S, Wailoo A; ESCAPE Research Team (Goodacre S, Johnson M, Lewis C, Morris F, Nicholl J, Oluboyede Y, Read S, Tod A, Adams P, Coats T, Cullum N, Gray A, Kendall J, Newby D, Dixon S, Benger J, Gray D, Prescott R, Hollingsworth J, Rodrigues E, McCarten P, Roe D, Johns D, Osula S, Randles K, Walter D, Lancaster C, Brett C, Bickerton G, Russell R, Okereke D, Chawla A, Lindley J, Housham J, McGugan S, Coffey F, Miller P, Mann C, Haffenden A, Capewell B, Keaney J, Langford N, Johnson R, Amos S, Baker S.) Cost effectiveness of chest pain unit care in the NHS. BMC Health Serv Res. 2008 Aug 13;8:174.
Kay N, Green A, McDowell SE, Ferner RE. Should doctors who make clinical errors be charged with manslaughter? A survey of medical professionals and members of the public. Med Sci Law 2008;48:317-324
Ferner RE. Post-mortem clinical pharmacology. Br J Clin Pharmacol. 2008 Jul 15. [Epub ahead of print]PMID: 1863788
Ormerod S, McDowell SE, Coleman JJ, Ferner RE.Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression : a systematic review and meta-analysis.Drug Saf. 2008;31(7):597-607.PMID: 18558793 [PubMed - in process]
Ferner RE, Beard K.Over the counter medicines: proceed with caution. BMJ 2008 Mar 29;336(7646):694-6.
Ferner RE. Did the drug cause death? Codeine and breastfeeding. The Lancet, 2008; 372(9639): 606-608
Computerised Pill Counting – How will technology support research into medication adherence?
Coleman JJ. British Journal of Clinical Pharmacology 2008; 66(1): 4-5.
Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression: A systematic review and meta-analysis Ormerod S, Mc Dowell SE, Coleman JJ, Ferner RE. Drug Safety 2008; 31(7): 597-607.
Ferner RE, Beard K. Over the counter medicines: proceed with caution. BMJ 2008;336:694-696 [link]
Cox AR. Assessing, managing and reporting adverse drug reactions may better equip us to minimise medicines-related harm. Pharmacy in Practice 2008;18(2):57-61
2007
Cheng K, Masters S, Stephenson T, Cooke R, Ferner R, Ashworth M, Nunn T. Identification of suspected fatal adverse drug reactions by paediatricians: a UK surveillance study. Arch Dis Child 2007; Published Online First: 22 June 2007. doi:10.1136/adc.2006.107789
Howard RL, Avery AJ, Coleman JJ, Ferner RE, Barber N. Design specification for NHS IT systems to minimise risk of harm to patients from medications. Presented at the Drug Utilisation Research Group – RSM London 2007 (voted best abstract)
Smellie WS, Coleman JJ. Pitfalls of testing and summary of guidance on safety monitoring with amiodarone and digoxin. BMJ 2007;334(7588):312-5.
Smellie WS, Forth J, Coleman JJ, Irvine W, Dore PC, Handley G, Williams DG, Galloway PJ, Kerr KG, Herriot R, Spickett GP, Reynolds TM. Best practice in primary care pathology: review 6. J Clin Pathol 2007; 60(3):225-34.
Thomas LJ, Coleman JJ. The medic’s guide to prescribing: Rational Prescribing. Student BMJ 2007; 15: 144-5.
Quasim S, Coleman JJ. Drugs of Abuse – A Review. CPD Anaesthesia 2007; 9(1): 29-36
Tenant R, Mohammed MA, Coleman JJ, Martin U. A systematic review of the uses of statistical process control charts to monitor clinical variables in individual patients. International Journal for Quality in Health Care August 2007; 19: 187 – 194
Alton DM, Coleman JJ. The medic’s guide to prescribing: What should I know about this drug? Student BMJ 2007; 15: 415-6.
Cox AR, Kirkham H. A Case Study of a Graphical Misrepresentation: Drawing the Wrong Conclusions about the Measles, Mumps and Rubella Virus Vaccine. Drug Safety 2007; 30(10): 831-836.
Cox AR, Anton C, Marriott JF, Ferner RE. The paradox of low prescribers who are high reporters: correlates of spontaneous reporting of adverse drug reactions within primary care. Drug Safety 2006; 30(10): 977-978
(Presented at the 7th Annual Meeting of ISoP Bournemouth – UK, 21-24 October 2009)
McDowell SE, Coleman JJ, Ferner RE. Rhabomylsis and statins – an analysis of spontaneous case reports using a three-diensional classification scheme. Drug Safety 2006; 30(10): 979
(Presented at the 7th Annual Meeting of ISoP Bournemouth – UK, 21-24 October 2009)
Ormerod S, McDowell SE, Coleman JJ, Ferner RE. Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses: systematic review and meta-analysis. Drug Safety 2006; 30(10): 975-976
(Presented at the 7th Annual Meeting of ISoP Bournemouth – UK, 21-24 October 2009)
Layton D, Cox A. Pharmacovigilance. In: Bond C editor. Using Medicines Information. Oxford, Radcliffe Publishing 2007. p. 141-168.
Langford NJ, Cox A. Interactions between Antihypertensive Drugs and Other Medications. In: Comprehensive Hypertension. Editors: Lip GHY, Hall JE. Philadelphia, Mosby Elsevier; 2007. 1075-1086.
Martin U, Coleman JJ. Drugs and the Elderly. In: Pharmacovigilance (2nd Ed.) Mann RD, Andrews EB (Eds). John Wiley and Sons Ltd.; Chichester, 2007.
Coleman JJ. Antihypertensive Drugs. In: Side Effects of Drugs Annual 29. Aronson JK (Ed). Elsevier; Amsterdam, 2007.
Ferner RE, McDowell S, Cotter A. Medical Errors and Lessons from Drug-Related Deaths. In: Mann RD, Andrews EB, eds. Pharmacovigilance. 2nd ed. Chichester: John Wiley and Son, 2007.
Coleman JJ, Ferner RE. Poisoning. In: An Insider’s Guide to the Medical Specialties. Reckless I, Reynolds J (Eds). Oxford University Press; Oxford, 2006.
Cox A. Chimeraphobia. The Philosophers’ Magazine 2007; 38: 14-16
Thomas LJ, Coleman JJ. The medic’s guide to prescribing: Rational prescribing. studentBMJ 2007;15:133-168
Cox A, McDowell S. Changing roles, changing risks — the paradox of pharmacist prescribing. The Pharmaceutical Journal. 2007; 278: 46. [text]
Cox AR. Serious ADRs Recognition and management of drug-induced blood disorders. Prescriber 2007; 18 (3) :51-56.
2006
Ferner RE, Aronson JK. Clarification of terminology in medication errors: definitions and classification. Drug Safety 2006; 29(11):1011-22 [abstract]
Aronson JK, Barnett DB, Ferner RE, Ferro A, Henderson G, Maxwell SR, Rawlins MD, Webb DJ. Poor prescribing is continual. BMJ 2006; 333(7571):756 [link]
Ferner RE, Aronson JK. Communicating information about drug safety. BMJ 2006;333(7559):143-5 [abstract]
Ferner RE, McDowell SE. Doctors charged with manslaughter in the course of medical practice, 1795-2005: a literature review. J R Soc Med 2006; 99(6):309-14 [full paper]
Ferner RE, McDowell SE. How NICE may be outflanked. BMJ 2006 ;332(7552):1268-71 [abstract]
Coleman JJ, Ferner RE. Poisoning. In: An Insider’s Guide to the Medical Specialties. Reckless I, Reynolds J (Eds). Oxford University Press; Oxford, 2006.
McDowell SE, Coleman JJ, Ferner RE. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ 2006; 332(7551):1177-81 [abstract]
Price JF, McDowell S, Whiteman MC, Deary IJ, Stewart MC, Fowkes FG. Ankle brachial index as a predictor of cognitive impairment in the general population: ten-year follow-up of the Edinburgh Artery Study. J Am Geriatr Soc 2006; 54:763-9 [abstract]
Coleman JJ, Ferner RE, Evans SJ. Monitoring for adverse drug reactions. Br J Clin Pharmacol 2006; 61(4):371-8 [abstract]
Langford NJ. e-Learning and error. Qual Saf Health Care 2006; 15(5):306 [extract]
Langford NJ, Bradberry SA, Vale JAV, Ferner RE. Methadone overdoses presenting to an inner city UK hospital 2004-2005. (abstract) Clin Tox 2006; 44: 522-3
Gull DG, Langford NJ. Drugs and driving. Adverse Drug Reaction Bulletin 2006; 238: 911-914
Martin U, Coleman JJ. Monitoring renal function in hypertension. BMJ
2006; 333(7574):896-9 [link]
Coleman JJ, Kendall MJ. The Anglo-Scandinavian Cardiac Outcomes Trial– blood pressure lowering arm. J Clin Pharm Ther 2006 Aug;31(4):299-307 [link]
Anton C, Cox AR, Coleman JJ, Ferner RE. A Comparison of Publically Available Spontaneous Adverse Drug Reaction Data from National Spontaneous Reporting Schemes. Drug Safety 2006; 29(10): 914 (Presented at the 6th Annual Meeting of ISoP Li̬ge РBelgium, 11-13 October 2006) [poster]
Anton C, Cox AR, Ferner RE. Targetted Follow-Up of Spontaneous ADR Reports to Improve Follow-Up Rates. Drug Safety 2006; 29(10):996
(Presented at the 6th Annual Meeting of ISoP Li̬ge РBelgium, 11-13 October 2006) [presentation]
Cox AR, Marriott JF, Wood KMG, Ferner RE. General Practitioners’ Attitudes towards
Adverse Drug Reaction Reporting: A Qualitative Study. Drug Safety 2006; 29(10):952 (Presented at the 6th Annual Meeting of ISoP Li̬ge РBelgium, 11-13 October 2006) [poster]
McDowell, Coleman JJ. Legal implications of Medication Errors: Charges of Manslaughter against Doctors and Pharmacists in the UK from 1795 to 2005 Drug Safety 2006; 29(10): 962 (Presented at the 6th Annual Meeting of ISoP Li̬ge РBelgium, 11-13 October 2006) [poster]
Cox AR, Higham C, Chandler ML, Situnayake RD. Methotrexate: Patient Knowledge of Key Safety Issues. Pharmacoepidemiology and Drug Safety 2006; 15: S288
(Presented at the 22nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management, August 24-27, 2006 Lisbon, Portugal) [poster]
Cox AR. Prevention and management of drug-induced ocular disorders. Prescriber 2006:17(12): 39-42 [PDF]
Cox A, Langford N. Partisan editorials serve no one, least of all new prescribers. Pharmaceut J 2006; 276: 621 [text]
Langford NJ, Bradberry SA, Vale JAV, Ferner RE. Methadone overdoses presenting to an inner city UK hospital 2004-2005.(abstract) Clin Tox 2006; 44: 522-3
Casiday RE, Cox AR. Restoring confidence in vaccines by explaining vaccine safety monitoring : is a targeted approach needed? Drug Safety 2006; 29(12): 1105-9 [abstract]
2005
Langford NJ, Graham-Clarke EM. Tablet markings should be considered in safe design. The Pharmaceutical Journal 2005; 275: 606.
Ferner RE, Langford NJ, Cox AR. Testamentary capacity. In Payne-James J, Byard R, Corey T, Henderson C. editors. Encyclopedia of Forensic and Legal Medicine. New York: Academic Press; 2005. p252-258.
Cox AR. Yellow Card Reporting Scheme: What to report and where to? Tomorrow’s Pharmacist.2005: 66-67
Ferner RE, Aronson JK. National differences in publishing papers on adverse drug reactions. British Journal of Clinical Pharmacology 2005; 59: 108-111.
Ferner RE, Coleman J. Anticipating, preventing and investigating medication errors. Clinical Medicine 2005: 5; 12-15.
Graham-Clarke E, Langford NJ. ‘All that glisters is not gold’. Pharmaceutical Journal 2004; 273: 284.
Langford NJ, Good AM, Laing WL, Bateman DN. Quinine intoxications: a continuing problem. British Journal of Clinical Pharmacology 2004; 57: 817.
Langford NJ, Landray M, Martin U, Ferner RE, Kendall MJ. Therapeutics OSCE- Journal of Clinical Pharmacy & Therapeutics 2004; 29: 263-6.
Coleman JJ, Ferner RE. Poisoning. In: Reckless IA, Reynolds DM, eds. Specialty secrets of Acute Medicine. Oxford: OUP, in press.
Ferner RE, Coleman JJ, Pirmohamed M, Constable S, Rouse AR. The quality of information on monitoring for haematological for adverse drug reactions. British Journal of Clinical Pharmacology 2005; 60: 448-451.
Aronson JK, Ferner RE. Clarification of terminology in drug safety. Drug Safety, 2005; 28:851-870.
Coleman JJ, Ferner RE, Evans SJW. Monitoring for Adverse Drug Reactions. British Journal of Clinical Pharmacology 2005, accepted for publication.
Ferner RE. The influence of the pharmaceutical industry. BMJ 2005; 330: 857-8.
Ferner RE, Beard K. Regulating herbal medicines in the UK. BMJ 2005; 331: 62-63.
2004
Anton C, Cox AR. Surprise at disdain for conventional medicines. Pharmaceutical Journal. 2004; 273: 114-5.
Anton C, Nightingale PG, Adu D, Lipkin G, Ferner RE. Improving prescribing using a rule based prescribing system. Quality and Safety in Health Care. 2004; 13:186-90.
Coleman JJ, Langford NJ, Ferner RE, Kendall MJ. Simulated Practical Therapeutics in an OSCE for final year medical students. Simulation in Medical Education. Association for the Study of Medical Education. January 2004.
Coleman JJ. Drug-induced seizures. Adverse Drug Reaction Bulletin 2004; 227: 871-4.
Cox AR, Langford NJ, Anton C. Do not forget about the yellow card scheme. Pharmaceutical Journal 2004; 272: 349.
Cox AR, Langford NJ. BANs to rINNS. Journal of Clinical Pharmacy and Therapeutics 2004; 29: 491-5.
Cox AR, Marriott JF, Wilson KA, Ferner RE. Adverse drug reaction teaching in UK undergraduate medical and pharmacy programmes. Journal of Clinical Pharmacy and Therapeutics 2004; 29: 31-5.
Cox AR. Colchicine in acute gout: optimal dose of colchicine is still elusive. BMJ 2004; 328: 288.
Anton C, Nightingale PG, Adu D, Lipkin G, Ferner RE. Improving prescribing using a rule based prescribing system. Qual Saf Health Care 2004; 13: 186-90. abstract | paper | poster
Anton C, Langford N, Poole CJ, Routledge PA, Hutchings A, Bateman DN, Sheehan T, Ferner RE. Comparison of preparation of infusion bags on the ward or in the pharmacy. Poster presented at the NPSA conference, Birmingham, 2004.
Cox AR, Langford N, Anton C. Do not forget about the yellow card scheme? Pharmaceut J. 2004: 272; 349. abstract | paper
Ferner RE. Computer aided prescribing leaves holes in the safety net. BMJ 2004; 328: 1172-3. abstract | paper
Lakie MD, Hayes N, Combes N, Langford NJ. Is postural tremor size controlled by interstitial potassium concentration in muscle? Journal of Neurology, Neurosurgery & Psychiatry2004;75: 1013-18. abstract| paper
Langford NJ, Landray M, Martin U, Kendall MJ, Ferner RE. Testing the practical aspects of therapeutics by objective structured clinical examination. J Clin Pharm Ther 2004; 29: 263-6. abstract| paper
Langford NJ, Coleman JJ, Landray M, Martin U, Kendall MJ, Ferner RE. Teaching final year medical students to avoid errors in prescribing and giving medicines. Poster presented at NPSA conference, Birmingham, 2004.
Langford NJ, Good AM, Laing WL, Bateman DN. Quinine intoxications: a continuing problem. Brit J Clin Pharm. 2004: 57; 817.
Cox AR. New Edition affirms place as key text in the area of pharmacovigilance. The Pharmaceutical Journal. 2004;272:393 [Book Review]
2003
Anton C, Cox AR, Watson RD, Ferner RE. The safety of spironolactone treatment in patients with heart failure. J Clin Pharm Ther 2003;28: 285-7. abstract
Anton C, Ferner RE. Medication errors detected in infusions. Arch Intern Med 2003; 163: 982. abstract
Anton C, Cox AR, Ferner RE. Using trade names: sometimes it helps. Arch Intern Med 2003; 162: 2636. abstract
Anton C. Co-trimoxazole is restricted. Pharmaceutical Journal 2003, 271, 612. text
Aronson JK, Ferner RE. Joining the DoTS: new approach to classifying adverse drug reactions. BMJ 2003; 327: 1222-5. abstract | paper
Chin BS, Langford NJ, Nuttall SL, Gibbs CR, Blann AD, Lip GYH. Antioxidant properties of beta-blockers and angiotensin converting enzyme inhibitors in congestive cardiac failure. Eur J Heart Failure. 2003; 5: 171-4.
Cox AR, Langford NJ. Drug induced heart failure. Adverse Drug Reaction Bulletin 2003: 220; 843-6.
Cox AR. Manufacturers should make reading labels easier. Pharmaceutical Journal 2003; 270: 514. letter
Cox AR, Anton C. Report all drug reactions with warfarin. Pharmaceutical Journal 2003; 270: 366-7. letter
Cox AR. Advertising: Prescribers need appraisal training programmes. Pharmaceutical Journal 2003; 270:154. abstract | letter
Ferner RE. Drugs of abuse. In: Neuberger J, ed. Horizons in Medicine No. 14. London: Royal College of Physicians, 2003: 73-84.
Ferner RE. Accuracy of pharmaceutical advertisements in medical magazines. Lancet 2003; 361: 879. abstract
Ferner RE, Daniels AM. Office-based treatment of opioid-dependent patients. New England Journal of Medicine 2003; 348: 81-2. abstract
Ferner RE. Adverse drug reactions. Medicine 2003; 31: 20-4.
Ferner RE. Is concordance the primrose path to health? BMJ 2003; 327: 821-2. paper
Ferner RE. Antidotes: principles and clinical applications. British Journal of Clinical Pharmacology 2003; 56: 458.
Hughes B, Durran A, Langford NJ, Mutimer D. Paracetamol poisoning-impact of pack size reduction. Journal of Clinical Pharmacy & Therapeutics 2003: 28; 307-10. abstract
Kerr KL, Higham C, Cox AR, Situnayake RD. A determination of patient awareness of the safety issues surrounding treatment with methotrexate. The Pharmaceutical Journal 2003; 271: 900-01. paper
Langford NJ, Martin U, Elliott S, Ferner RE, Krentz S. Severe
relapsing sulphonyl-urea induced hypoglycaemia: A diagnostic and
therapeutic challenge. Post-Graduate Medical Journal. 2003; 79: 120.
abstract
| paper
Langford NJ, Aruna RS, Mutimer D, White AC, Ferner RE. The impact of
pack size legislation on paracetamol (acetaminophen) poisoning in
the West Midlands (United Kingdom). J Tox Clin Tox 2003: 41; 419-20.
abstract | paper
Langford NJ, Good AM, Laing WL, Bateman DN. Reported quinine
intoxications to the Scottish Poisons Information Bureau 1997-2002.
Brit J Clin Pharm.2003; 56: 576-8. abstract
| paper
Langford NJ, Munyame C, Patel H, Hamlyn AN, Ferner RE. Mirtazapine
overdose and miosis. J Tox Clin Tox.2003: 41;1037-8. abstract
| paper
Nuttall SL, Khan J, Thorpe GH, Langford NJ, Kendall MJ. The impact
of therapeutic doses of paracetamol on serum total antioxidant
capacity. Journal of Clinical Pharmacy & Therapeutics 2003: 28;
289-94. abstract
| paper
Pirmohamed M, Ferner RE. Monitoring drug treatment. BMJ 2003; 327:
1179-81. abstract | paper
Whitaker S, Cox AR, Alexander AM. Internet networking for
pharmacists: an evaluation of a mailing list for UK pharmacists.
International Journal of Pharmacy Practice 2003; 11: 25-32. abstract
| paper
2002
Anton C. Statins as the new aspirin. National Institute for
Clinical Excellence should assess statins. British Medical Journal
2002; 324: 789.
Anton C. Adverse effects of laxatives. Adverse Drug Reaction
Bulletin 2002; 212: 811-14. Anton C. ADRs in children. Prescriber
2002; 13(9): 23.
Anton C, Cox AR, Ferner RE. Using trade names: sometimes it helps.
Archives of Internal Medicine 2002; 162: 2636-7.
Cox AR. Systemic effects of ocular drugs Adverse Drug Reaction
Bulletin 2002; 215: 823-6. Cox AR. Embracing ADR reporting could
improve pharmacists’ standing. The Pharmaceutical Journal 2002; 269:
14.
Cox A. Childhood vaccination, a social responsibility. The
Pharmaceutical Journal 2002; 268: 570.
Cox A. Book Review – Martindale 33rd edition. The Pharmaceutical
Journal 2002; 268: 505. Cox A. Overwhelming evidence for safety of
MMR. The Pharmaceutical Journal 2002; 268: 398.
Cox A, Jenkins A. A case of carboplatin hypersensitivity. Pharmacy
in Practice 2002; 12: 187.
Cox A, Millane T. An adverse drug reaction as a consequence of
error. Pharmacy in Practice 2002; 12: 84-6.
Cox AR, Marriott JF. Take a spoonful of sugar with salt. The
Hospital Pharmacist 2002; 9: 90.
Cox AR. Marriott JF. Safety First. Drugs with similar sounding names
have lead to deaths. What can be done to prevent any more mishaps?
Pharmaceutical Marketing Feb 2002: 48-50.
Cox AR, Marriott JF, Wilson KA, Ferner RE. Adverse drug reaction
teaching in UK undergraduate medical and pharmacy programs.
Pharmacoepidemiology and Drug Safety 2002; 11: s157.
Dent SN, Cox AR, Marriott JF, Langley CA, Wilson KA. Warfarin
toxicity: do discharge ICD-codes and yellow cards accurately
identify serious adverse drug reactions? The International Journal
of Pharmacy Practice 2002; 10(suppl): R40.
Ferner RE. Medicines management: a sour taste. Quarterly Journal of
Medicine 2002; 95: 181-4.
Ferner RE, Whittington RM. Medical Errors and Lessons from
Drug-Related Deaths. In: Mann RD, Andrews EB, eds.
Pharmacovigilance. Chichester: John Wiley and Son, 2002:
509-514.
Ferner RE, Thomas M. Emergency Medicine. In: van Boxtel CJ, Santoso
B, Edwards IR, eds. Drug benefits and risks: International textbook
of clinical pharmacology. 1st ed. Chichester: John Wiley & Sons,
Ltd, 2001: 442-57.
Ferner RE, Kendall MJ. Drug therapy: special considerations in
diabetes. In: Pickup J, Williams G, eds. Textbook of Diabetes, 3rd
ed. Oxford: Blackwell Science, 2002: 39.1-39. Gittoes NJL, Ayuk J,
Ferner RE. Drug-induced diabetes. In: Pickup J, Williams G, eds.
Textbook of Diabetes, 3rd ed. Oxford: Blackwell Science, 2002:
26.1-26. Jenkins A, Cox A. Influenza vaccine and warfarin. Pharmacy
in Practice 2002; 12: 140.
Langford NJ. Aspirin and Reye’s syndrome: is the response
appropriate? Journal of Clinical Pharmacology and Therapeutics 2002;
27: 157-60.
Langford NJ. Serotonin syndrome. Adverse Drug Reaction Bulletin.
2002; 217; 831-4. Langford NJ, Martin U, Ruprah M, Ferner RE.
Alternative venlafaxine kinetics in overdose. Journal of Clinical
Pharmacy and Therapeutics 2002; 27: 465-7.
Langford NJ, Kendall MJ. Rhabdomyolysis with HMG CoA reductase
inhibitors: a class effect? Journal of Clinical Pharmacy &
Therapeutics 2002; 26: 391-5.
Langford NJ, Ferner RE. Episodes of environmental poisoning
worldwide. Occupational and Environmental Medicine 2002; 59:
855-60.
Langford NJ, Cox AR. Medication errors: Over reliance on any safety
system is not ideal The Pharmaceutical Journal 2002; 269: 248.
Maxwell S, Walley T, Ferner RE. Using drugs safely. British Medical
Journal 2002; 324: 930-1.
Rippengill KL, Higham C, Cox AR, Situnayake RD. Methotrexate -
patient awareness and safety issues. Pharmacy World & Science
2002; 24: A21.
- Admin
- Comments Off